Global Clinical Trial Equipment & Ancillary Solutions Market by Product (Supply/Logistics, Sourcing), by Phase (Phase I, II, III) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global clinical trial equipment and ancillary solutions market was valued at USD2.3 billion in 2020. It is expected to grow at an 8.2% compound annual growth rate (CAGR), between 2021 and 2028. Due to the increasing R&D investments and evolving clinical trial needs, the global market will experience significant growth. The process of clinical trial has been slowed by the COVID-19 epidemic. The market is moving towards a decentralized approach for clinical trials in order to increase patient retention. The industry supply chain has been affected by the pandemic, which has led to a shortage of equipment and auxiliary supplies.
Logistics problems have also been created by lockdowns in the transport of ancillary goods between different regions around the globe. The pandemic has seen a significant increase in clinical trials. Clinical trials are becoming more complex and require more resources, including drugs, equipment, and ancillary supply. Ancillary supplies are all the items required to conduct a clinical trial, including syringes and surgical knives, swabs and gloves.
It is more than simply procuring the equipment and ancillary material for clinical trials. You need to have a deep understanding of the requirements and design of your study. Proactive planning is essential in order to ensure that you get the best equipment and supplies at the right price. It is highly recommended that you have both internal and external knowledge to manage the complex issues of equipment supply and logistics. The ideal scenario would see research managers and project managers able to concentrate on the execution of the clinical trial, while an expert partner handles the logistics and equipment.
Product Insights
The market can be divided by product into supply/logistics and service. The market was dominated by the supply/logistics segment, which accounted for more than 38% of the total revenue in 2020. As clinical trials have become more global and diverse, they require a proper cold chain logistics system to maintain the integrity of temperature-sensitive drugs.
The increasing complexity of clinical trials has led to an increase in the amount of equipment and ancillary supply required. This has also increased the number of suppliers needed to supply them. It is becoming more difficult to ensure that supplies reach research sites in a cost-effective way for global research. The single point of contact for all supplies, transport equipment and other supplies around the globe is now possible thanks to sourcing and distribution expertise. This coordinated and simplified process reduces strain on both facilities and clinical trial teams.
Phase Insights
The global market was sub-segmented on the basis of its phase into phases I, II and III. In 2020, the highest revenue share of the global marketplace was held by the phase III segment. It accounted for more than 53% of its total revenue. This segment will likely continue to be dominant in the future. Phase III clinical studies are more complex than those in the earlier stages. Despite the relatively small number of medicines involved in this phase, the complications that come with it are quite severe.
This phase also has the highest failure rate because of the large sample size and research design. Most failures are due to non-compliances with safety requirements. This scenario will likely increase demand for efficient supply chain and logistics, which will boost market growth in the future.
Regional Insights
With a revenue share of more than 41%, North America dominated global markets in 2020. This is due to the fact that the majority of pharmaceutical companies are located in the U.S., and do most of their business here. The forecast period will see regional market growth due to favorable regulatory policies, technologically advanced products being introduced by market players, as well as increased investments by pharmaceutical companies.
Asia Pacific is expected to be the fastest growing regional market, with a CAGR exceeding 9% during the forecast period. Because of its ease of regulatory compliance and low study costs, the region of Asia Pacific has been a hub for clinical trials. There are also a few elite medical institutions that serve as sites.
Market Share Insights and Key Companies
To maintain market share, key players adopt a variety of strategies such as acquisitions, mergers, and collaborations. Parexel, a well-known global clinical research company, announced in July 2021 that it had signed a final merger agreement. It would be bought from Pamplona Capital Management by the EQT II fund and the venture capital division of Goldman Sachs Management for $8.5 Billion. The following are some of the most prominent players in global clinical trial equipment and ancillary solutions markets:
-
Ancillare, LP
-
Imperial Clinical Research Services
-
Woodley Equipment Company Ltd.
-
Thermo Fisher Scientific, Inc.
-
PPD, Inc.
-
PAREXEL International Corp.
-
MediCapital Rent
-
Quipment SAS
-
IRM
-
Marken
-
Myonex
-
Youway
Up Market Research published a new report titled “Clinical Trial Equipment & Ancillary Solutions Market research report which is segmented by Product (Supply/Logistics, Sourcing), by Phase (Phase I, II, III), By Players/Companies PPD Inc, Ancillare LP, Yourway , Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc, Myonex, IRM, Imperial Clinical Research Services, Quipment SAS, PAREXEL International Corp, Marken, MediCapital Rent”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Clinical Trial Equipment & Ancillary Solutions Market Research Report |
By Product | Supply/Logistics, Sourcing |
By Phase | Phase I, II, III |
By Companies | PPD Inc, Ancillare LP, Yourway , Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc, Myonex, IRM, Imperial Clinical Research Services, Quipment SAS, PAREXEL International Corp, Marken, MediCapital Rent |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 204 |
Number of Tables & Figures | 143 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Clinical Trial Equipment & Ancillary Solutions Market Report Segments:
The market is segmented by Product (Supply/Logistics, Sourcing), by Phase (Phase I, II, III).
Clinical Trial Equipment & Ancillary Solutions Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Clinical Trial Equipment & Ancillary Solutions Market
Overview of the regional outlook of the Clinical Trial Equipment & Ancillary Solutions Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Clinical Trial Equipment & Ancillary Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Clinical Trial Equipment & Ancillary Solutions Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Supply/Logistics
2. Sourcing
7. By Phase:1. Phase I
2. II
3. III
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trial Equipment & Ancillary Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Clinical Trial Equipment & Ancillary Solutions Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trial Equipment & Ancillary Solutions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Trial Equipment & Ancillary Solutions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Trial Equipment & Ancillary Solutions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Trial Equipment & Ancillary Solutions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Trial Equipment & Ancillary Solutions Market Size & Forecast, 2018-2028
4.5.1 Clinical Trial Equipment & Ancillary Solutions Market Size and Y-o-Y Growth
4.5.2 Clinical Trial Equipment & Ancillary Solutions Market Absolute $ Opportunity
Chapter 5 Global Clinical Trial Equipment & Ancillary Solutions Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Product
5.2.1 Supply/Logistics
5.2.2 Sourcing
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Clinical Trial Equipment & Ancillary Solutions Market Analysis and Forecast by Phase
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Phase
6.1.2 Basis Point Share (BPS) Analysis by Phase
6.1.3 Absolute $ Opportunity Assessment by Phase
6.2 Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Phase
6.2.1 Phase I
6.2.2 II
6.2.3 III
6.3 Market Attractiveness Analysis by Phase
Chapter 7 Global Clinical Trial Equipment & Ancillary Solutions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Trial Equipment & Ancillary Solutions Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Product
9.6.1 Supply/Logistics
9.6.2 Sourcing
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
9.10 North America Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Phase
9.10.1 Phase I
9.10.2 II
9.10.3 III
9.11 Basis Point Share (BPS) Analysis by Phase
9.12 Absolute $ Opportunity Assessment by Phase
9.13 Market Attractiveness Analysis by Phase
Chapter 10 Europe Clinical Trial Equipment & Ancillary Solutions Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Product
10.6.1 Supply/Logistics
10.6.2 Sourcing
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
10.10 Europe Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Phase
10.10.1 Phase I
10.10.2 II
10.10.3 III
10.11 Basis Point Share (BPS) Analysis by Phase
10.12 Absolute $ Opportunity Assessment by Phase
10.13 Market Attractiveness Analysis by Phase
Chapter 11 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Product
11.6.1 Supply/Logistics
11.6.2 Sourcing
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
11.10 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Phase
11.10.1 Phase I
11.10.2 II
11.10.3 III
11.11 Basis Point Share (BPS) Analysis by Phase
11.12 Absolute $ Opportunity Assessment by Phase
11.13 Market Attractiveness Analysis by Phase
Chapter 12 Latin America Clinical Trial Equipment & Ancillary Solutions Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Product
12.6.1 Supply/Logistics
12.6.2 Sourcing
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
12.10 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Phase
12.10.1 Phase I
12.10.2 II
12.10.3 III
12.11 Basis Point Share (BPS) Analysis by Phase
12.12 Absolute $ Opportunity Assessment by Phase
12.13 Market Attractiveness Analysis by Phase
Chapter 13 Middle East & Africa (MEA) Clinical Trial Equipment & Ancillary Solutions Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Product
13.6.1 Supply/Logistics
13.6.2 Sourcing
13.7 Basis Point Share (BPS) Analysis by Product
13.8 Absolute $ Opportunity Assessment by Product
13.9 Market Attractiveness Analysis by Product
13.10 Middle East & Africa (MEA) Clinical Trial Equipment & Ancillary Solutions Market Size Forecast by Phase
13.10.1 Phase I
13.10.2 II
13.10.3 III
13.11 Basis Point Share (BPS) Analysis by Phase
13.12 Absolute $ Opportunity Assessment by Phase
13.13 Market Attractiveness Analysis by Phase
Chapter 14 Competition Landscape
14.1 Clinical Trial Equipment & Ancillary Solutions Market: Competitive Dashboard
14.2 Global Clinical Trial Equipment & Ancillary Solutions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PPD Inc
14.3.2 Ancillare LP
14.3.3 YourwayÂ
14.3.4 Woodley Equipment Company Ltd
14.3.5 Thermo Fisher Scientific Inc
14.3.6 Myonex
14.3.7 IRM
14.3.8 Imperial Clinical Research Services
14.3.9 Quipment SAS
14.3.10 PAREXEL International Corp
14.3.11 Marken
14.3.12 MediCapital Rent